PATENT CLAIM ANALYSIS

Application Number: 15946774
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["530", "391900"]

Abstract:
Provided are antibody drug conjugates that bind PRLR, in particular human PRLR, their methods of making, and uses thereof.

Claim (Index 17):
The ADC of  claim 12 , wherein the heavy chain constant region of the anti-PRLR antibody either lacks a C; terminal lysine or comprises an amino acid other than lysine at a C-terminus of the heavy chain constant region.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.15
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15363786', '15363715', '14928738', '15819153', '15349692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7577961513124932
- 35 USC 102 Novelty (BERT): 0.5462415787197273
- Combined Prediction Score: 0.7366406940532166
- Mean Citation Score: 419.718152
- Max Citation Score: 457.7913
- Similarity Product: 258.0411935192764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test